Skip to main content
. 2021 Jan 12;8(1):68–78. doi: 10.1089/lgbt.2020.0185

Table 3.

Unadjusted and Adjusted Models Measuring Disparities in Health Risk and Protective Behaviors among Women Surviving Cancer by Self-Reported Sexual Orientation: National Health Interview Survey, 2013–2018 (n = 11,066)

  Heterosexual
Lesbian
χ2
pa
Bisexual
χ2
pa
Lesbian
Bisexual
Weighted % (95% CI) Weighted % (95% CI) aORb(95% CI) aORb(95% CI)
Heterosexual vs. lesbian Heterosexual vs. bisexual
Tobacco use     77.6 <0.001   60.6 <0.001    
 Current smoker 13.3 (12.9–13.7) 21.3 (18.4–24.3)     23.0 (19.9–26.1)     2.34 (1.26–4.34) 1.27 (0.68–2.39)
 Former smoker 18.9 (18.5–19.3) 25.4 (22.3–28.5)     18.2 (15.6–20.9)     1.89 (1.21–2.96) 1.82 (0.91–3.64)
 Never smoker 67.8 (67.3–68.3) 53.2 (49.6–56.8)     58.8 (55.3–62.4)     Ref. Ref.
Heavy drinking 6.5 (6.3–6.8) 11.8 (9.5–14.1) 85.2 <0.001 13.4 (10.9–15.9) 53.7 <0.001 0.67 (0.27–1.66) 2.06 (0.88–4.81)
Binge drinking 29.6 (29.0–30.3) 43.6 (39.5–47.8) 50.1 <0.001 55.1 (50.7–59.6) 146.2 <0.001 1.45 (0.81–2.58) 1.65 (0.96–2.84)
Meeting physical activity guidelines 33.7 (33.1–34.3) 42.3 (38.8–45.7) 25.5 <0.001 44.9 (41.1–48.6) 37.8 <0.001 1.39 (0.85–2.26) 0.93 (0.56–1.50)
Preventive health care
 Pap 44.2 (43.7–44.8) 41.1 (37.4–44.9) 2.5 0.113 42.1 (38.1–46.1) 1.1 0.293 0.56 (0.31–1.01) 0.60 (0.31–1.56)
 Mammogram 45.1 (44.5–45.7) 44.8 (40.6–49.0) 0.02 0.887 29.2 (24.4–34.0) 34.6 <0.001 1.06 (0.66–1.70) 0.42 (0.23–0.78)
 Visit with ob/gyn 39.6 (39.1–40.1) 33.7 (30.5–36.9) 12.3 <0.001 42.0 (38.0–46.0) 1.4 0.238 0.75 (0.45–1.24) 0.81 (0.45–1.48)
 HPV vaccine 13.6 (13.2–14.0) 16.3 (13.0–19.5) 3.0 0.084 38.0 (34.1–42.0) 286.2 <0.001 0.76 (0.15–3.92) 0.80 (0.32–2.00)

Significant (p ≤ 0.05) results are bolded. Heterosexual women serve as the reference group in all analyses. Regression models were adjusted for differences in age, race/ethnicity, education level, insurance type, cancer site (breast, gynecologic, and other), and survey year.

a

p Value for Rao-Scott Chi-square test for the difference.

b

Regression models estimate aORs using logistic and multinomial regression models.

HPV, human papillomavirus; ob/gyn, obstetrician/gynecologist.